SEC Form 4 · accession 0001140361-15-017795

BIOMARIN PHARMACEUTICAL INC · BMRN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Executive Officer · Director

Period of report

Apr 30, 2015

Accepted (ET)

May 5, 2015 · 7:02 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001048477

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Apr 30, 2015	A	908	$51.2635	A	252,159	D
Common Stock^F2,F3	May 1, 2015	M	23,218	$6.46	A	56,476	I	Shares held by Bienaime Family Trust
Common Stock^F2,F4,F3	May 1, 2015	S	23,218	$114.9762	D	33,258	I	Shares held by Bienaime Family Trust
Common Stock^F4	May 1, 2015	S	3,505	$114.9762	D	248,654	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (right to buy) Common Stock^F3,F5,F6	$6.46	Apr 1, 2015	M	23,218	D	Nov 11, 2005	May 10, 2015	Common Stock	23,218	0	I

F1The reporting person is reporting the purchase of shares of the issuer's Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of November 1, 2014 to April 30, 2015.
F2Trade made pursuant to a 10b5-1 plan executed October 28, 2014.
F3The reporting person an his spouse act as trustees for the Bienaime Family Trust
F4The price in column 4 is an average weighted price. The price actually received ranged from $112.80 to $119.50. The issuing person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the amount of shares sold at each price within the range.
F5Original option grant vests 6/48th on November 11, 2005, and 1/48th on the 11th day of every month thereafter.
F6Reflects the numbers of stock options outstanding after the transaction from this specific stock option grant.